Our Journey and Achievements
Since 2010, LSDSS has grown from a small group of parents into a national voice for people with lysosomal storage disorders. These are some of the milestones along the way.
At a glance
Founded
2010, by parents and caregivers
Families registered
370+ online, from 27 states and union territories
A first for India
Rare Disease Day, New Delhi, 2010
Landmark
Delhi High Court order leading to a national rare disease policy
Recognition
Global Genes “Champions of Hope” Award, 2022
Milestones from 2010 to today
A timeline of LSDSS’s advocacy and achievements for LSD patients in India.
2010
- LSDSS is founded by like-minded parents and caregivers of LSD patients in India.
- India’s first International Rare Disease Day is commemorated in New Delhi.
- With the efforts of LSDSS, the first LSD Task Force is set up by ICMR in collaboration with AIIMS, New Delhi.
2011
- LSDSS wins Genzyme’s Patient Advocacy Leadership (PAL) Award for its Continuing Medical Education Programme, which gives doctors in four locations in India information about LSDs to help them make more accurate diagnoses.
2012–13
- LSDSS secures the first ever approval from the Employees’ State Insurance Corporation (ESIC) for enzyme replacement therapy for a young patient with MPS I (Hurler syndrome).
- 400 patients write to the then Prime Minister of India on International Rare Disease Day in Mumbai, appealing for support for the treatment of LSD patients.
2014
- LSDSS pioneers and persuades Shire plc (now Takeda) to start an international charitable access programme in India for LSD treatment, securing treatment for 35 children in the first group.
- The late former President of India, Dr A. P. J. Abdul Kalam, praises LSDSS’s efforts to create awareness about LSDs across India.
- On LSDSS’s representation, the Drugs Controller General of India (DCGI) simplifies the approval process for importing life-saving drugs for LSDs and orders import permits to be issued on the same day.
2015–16
- LSDSS gets its first judicial order in August 2015 in Karnataka, enabling treatment for LSD children in the state at the state’s expense.
- LSDSS asks the Ministry of Health and Family Welfare and ICMR to set up a national rare disease patient registry.
2017–18
- A major breakthrough: following a petition by LSDSS, the Delhi High Court directs the Ministry of Health and Family Welfare to formulate a national policy for rare diseases. A National Policy for the Treatment of Rare Diseases (NPTRD) is then drafted by a court-appointed panel of genetic experts from across India. Its biggest highlight is a ₹100 crore corpus fund for LSD patients, shared by the central and state governments in a 60:40 ratio.
- LSDSS wins a case in the High Court of Kerala to start treatment for LSD patients in the state at the state’s expense.
- After significant efforts, LSDSS secures an IGST exemption from the Ministry of Finance on imports of life-saving LSD drugs received through international charitable access programmes.
2019
- In a major setback for the LSD community, the Government of India scraps the NPTRD, calling it unimplementable, and asks the court for more time to redraft the policy.
2020–21
- The Government of India notifies a new National Policy for Rare Diseases (NPRD), which proposes crowdfunding and CSR donations for the treatment of Group 3 rare diseases such as LSDs. Since then, LSDSS has been advocating to close the gaps in the policy and ensure it is implemented effectively.
2022
- LSDSS wins the prestigious Global Genes “Champions of Hope” Award in the Foundations category, presented at the Global Genes Patient Advocacy Summit 2022 in San Diego, California, in recognition of its impactful work for LSD patients in India.
2023–25
- LSDSS continues to mark Rare Disease Day with patients, families and doctors across India, including events in Kerala, Hyderabad, Bhopal and Delhi in 2023.
- In 2025, LSDSS takes part in awareness programmes with Centres of Excellence: on LSDs at IPGMER & SSKM Hospital, Kolkata, in June, and for Gaucher Disease Awareness Month at AIIMS Bhopal in October.